A male patient with metachronous triple cancers of small cell lung, prostate and breast

Breast Cancer

Volumn 9, Issue 2, 2002, Pages 170-174

  Baba, Masashi ^a   Higaki, Naozumi ^a   Ishida, Masatoshi ^a   Kawasaki, Hiroyasu ^a   Kasugai, Tsutomu ^b   Wada, Akira ^b  

^a Kashiwara Municipal Hospital   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Male breast cancer; Prostatic cancer; Small cell lung cancer

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST TUMOR; CASE REPORT; DOPPLER FLOWMETRY; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; MASTECTOMY; METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE TUMOR; SMALL CELL CARCINOMA; TREATMENT OUTCOME;

BIOPSY, NEEDLE; BREAST NEOPLASMS, MALE; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PROSTATIC NEOPLASMS; TAMOXIFEN; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER;

EID: 0036371634     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967583     Document Type: Article

References (37)

1. The Japan Lung Cancer Society: General rule for clinical and pathological record of lung cancer. 5th ed, Kanehara & Co. Ltd., Tokyo, pp26-32, pp78-100, 1999 (in Japanese).
2. Shida K Fundamental and clinical study on anti-androgens -Androgen-dependency of prostatic tumors and clinical application of anti-androgens-. Asian Med J 24:747-777, 1981.
3. The Japanese Breast Cancer Society: General rules for clinical and pathological recording of breast cancer. 13th ed, Kanehara & Co. Ltd., Tokyo, pp7-14, 1998 (in Japanese).
4. Japanese Urological Association, The Japanese Society of Pathology: General rule for clinical and pathological studies on prostatic cancer. 2nd ed, Kanehara & Co. Ltd., Tokyo, pp66-93, 1992 (in Japanese).
5. Boring CC, Squires TS, Tong T: Cancer Statistics. CA Cancer J Clin 44:7-26, 1994. (Pubitemid 24035713)
6. Hiranuma T, Koyama S, Nakahara A: An autopsy case of synchronous primary cancer of the liver and male breast. Jpn J Gastroentero1 84:1471-1475, 1987 (in Japanese).
7. Ohsawa T, Mouri Y, Suzuki Y: Sigmoid colon cancer heterochronously developed 5 years after operation for male breast cancer. JJpn Surg Assac 55:679-682, 1994 (in Japanese with English abstract.
8. Kojima A, Ikeuchi T, Inomata M: Y/6 chromosome translocation in a male with triple primary cancers involving the breast. J Cancer Res Clin Oncol 117:479-483, 1991.
9. Gardini GF: Ginecomastia con degenerazione cancerigna in prostatico dopo trattamento estrogeno. Oncologia 1:129-142, 1948 (in Italian with English summary).
10. Abramson W, Warshawsky H: Cancer of the breast in the male, secondary to estrogenic administration: report of a case.J Uro1 59:76-82, 1948.
11. Reimann-Hunziker G: Brustdrusenkarzinom nach ovocyclinbehandlung eines prostatakarzinoms. Helvetica Chirurgica Acta 15:242-248, 1948 (in Dutch with English summary).
12. Howard RR, Grosjean WA: Bilateral mammary carcinoma in the male coincident with prolonged stilbestrol therapy. Surgery 25:300-303, 1949.
13. Claisse R, Daymas: Tumeur mammaire d'evolufion rapide, au cours du traitement d'un cancer de la prostate par les oestrogenes de synthese. Soc Med Hop Paris 67:1137-1140, 1951 (in French).
14. McClure JA, Higgins CC: Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7-9, 1951.
15. Gibba A Carcinoma mammario bilaterale comparso in corso di terapia estrogena per cancro prostafico. Urologia 19:180-185, 1952 (in Italian).
16. Graves GY, Harris HS: Carcinoma of the male breast with axillary metastasis following stilbestrol therapy. Ann Surg 135:411-414, 1952.
17. Jakobsen AHI: Bilateral mammary carcinoma in the male following stilbestrol therapy. Acta Pathol Microbiol Scand 31:61-66, 1952.
18. Gwynne JF, Dawson EO: Carcinoma of the breast in a male with carcinoma of the prostate. Aust NZJ Surg 26:235-238, 1957.
19. O'Grady WP, McDivitt RW: Breast cancer in a man treated with diethylsfilbestrol. Arch Pathol 88:162-165, 1969.
20. Wilson SE, Hutchinson WB: Breast masses in males with carcinoma of the prostate. J Surg Oncol 8:105-112, 1976.
21. Sobin LH, Shefif M: Relation between male breast cancer and prostate cancer. BrJ Cancer 42:787-790, 1980. (Pubitemid 11196091)
22. Choudhury M, Wajsman Z, DeRosas J, et al: Metastatic prostatic carcinoma to breast or primary breast carcinoma? Urology 19:297-299, 1982. (Pubitemid 12191915)
23. Schlappack OK, Braun O, Maier U: Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma. Cancer Detect Prey 9:319-322, 1986.
24. Moldowin RM, Orihuela E: Breast masses associated with adenocarcinoma of the prostate. Cancer 63:2229-2233, 1989. (Pubitemid 19136861)
25. Tajika M, Tuchiya T, Yasuda M, et al: A male case of synchronous double cancers of the breast and prostate. Internal Medicine 33:31-35, 1994. (Pubitemid 24097612)
26. Terauchi M, Naitoh H: A case report of prostata carcinoma with estrogen induced breast carcinoma. Rinsho Hinyokika 49:157-159, 1995 (in Japanese with English abstract).
27. Tanaka S, Fukutomi T, Fukami & Male breast cancer in patients with a familial history of breast cancer. Surg Today Jpn J Surg 26:975-979, 1996. (Pubitemid 27065780)
28. Sagman U, Lishner M, Maki E: Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Onco1 10:1525-1533, 1992. (Pubitemid 23057980)
29. Ribeiro GG, Phillips HV, Skinner LG: Serum oestradiol-17fl, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer. Br J Cancer 41:474477, 1980.
30. Mabuchi K, Bross DS, Kessler II: Risk factors for male breast cancer.JNC1 74:371-375, 1985. (Pubitemid 15112124)
31. Thomas DB, Jimenez LM, McTiernan & Breast cancer in men: risk factors with hormonal implications. Am J Epidemio1 135:734-748, 1992.
32. Boffetta P, Kaldor JM: Secondary malignancies following cancer chemotherapy. Acta Onco1 33:591-598, 1994. (Pubitemid 24345361)
33. Fernandes ET, Manivel JC, Reddy PK, et al: Cyclophosphamide associated bladder cancer - a highly aggressive disease: analysis of 12 cases. J Urol 156:1931-1933, 1996. (Pubitemid 26378021)
34. Sfine KC, Saylors RL, Sawyer JR, et al: Secondary acute myelogenous leukemia following safe exposure to etoposide.J Clin Oncol 15:1583-1586, 1997. (Pubitemid 27167396)
35. Yagita M, Ieki Y, Onishi R, et al: Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. Int J Oncol 13:91-96, 1998. (Pubitemid 28267500)
36. Balci A, Huusko P, Paakkonen K, et al: Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: a novel mutation BRCA2 3414de14 found in male breast cancer. Eur J Cancer 35:707-710, 1999. (Pubitemid 29258137)
37. Haraldsson K, Loman N, Zhang QX, et al: BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58:1367-1371, 1998. (Pubitemid 28193591)